RELMADA THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.705 USD | 0.00% |
|
+8.91% | +139.13% |
| 07-01 | Relmada Therapeutics, Inc.(NasdaqGS:RLMD) added to Russell Microcap Growth Index | CI |
| 07-01 | Relmada Therapeutics, Inc.(NasdaqGS:RLMD) added to Russell 3000E Growth Index | CI |
Chart calendar Relmada Therapeutics, Inc.
4b7607e8179636.zVY4IOvhDdVwHCDE-95dV5CS0c0kO9O7I1FucjXhxak._BwJWqWjaLAzZmepj7c6YvH_pbd3bZjobxUgR22wsf__GW943rVdljhmVw~ecd39c251ae97b1bb7518ffdba200750
Upcoming events on Relmada Therapeutics, Inc.
Past events on Relmada Therapeutics, Inc.
| 12/06/2024 16:20 | Goldman Sachs Global Healthcare Conference |
| 06/06/2024 12:30 | Jefferies Global Healthcare Conference |
| 24/05/2024 14:30 | Annual General Meeting |
| 08/05/2024 21:30 | Q1 2024 Earnings Call |
| 08/05/2024 21:05 | Q1 2024 Earnings Release |
| 19/03/2024 20:30 | Q4 2023 Earnings Call |
| 19/03/2024 20:15 | Q4 2023 Earnings Release |
| 10/03/2024 | Leerink Partners Global Biopharma Conference |
| 11/11/2023 13:00 | AASLD Liver Meeting - Abstract Number: 2468-C |
| 08/11/2023 21:30 | Q3 2023 Earnings Call |
| 08/11/2023 21:01 | Q3 2023 Earnings Release |
| 12/10/2023 19:30 | Jefferies Inaugural Biotech CNS/Neuro Summit |
| 08/10/2023 11:35 | European College of Neuropsychopharmacology Congress - Poster No: P.0399 |
| 08/10/2023 11:35 | European College of Neuropsychopharmacology Congress - Poster No: P.0166 |
| 08/10/2023 11:35 | European College of Neuropsychopharmacology Congress - Poster No: P.0165 |
| 08/08/2023 21:30 | Q2 2023 Earnings Call |
| 08/08/2023 21:01 | Q2 2023 Earnings Release |
| 14/06/2023 23:20 | Goldman Sachs Global Healthcare Conference |
| 08/06/2023 20:00 | Jefferies Global Healthcare Conference |
| 01/06/2023 17:30 | American Society of Clinical Psychopharmacology Meeting - Poster No T46 |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -60,8 -64,2 5.26% | -85,2 -98,7 13.67% | -161 -152 -6.08% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -60,8 -59,2 -2.77% | -126 -127 0.87% | -161 -162 0.48% | -104 -103 -0.74% | -105 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -59,5 -56,6 -5.08% | -126 -127 0.6% | -157 -158 0.82% | -98,8 -98,9 0.1% | -102 |
|
Net income Million USD | Released Forecast Spread | -59,5 -56,6 -5.08% | -126 -126 0.56% | -157 -159 0.99% | -98,8 -99,3 0.51% | -102 |
|
EPS USD | Released Forecast Spread | -3,81 -3,56 -7.08% | -7,16 -7,16 -0.02% | -5,30 -5,37 1.3% | -3,28 -3,28 -0.12% | -3,01 |
| Announcement Date | 23/03/21 | 23/03/22 | 23/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -38,3 -34,1 -12.31% | -45,5 -38,3 -18.94% | -38,7 -44,1 12.08% | -38,7 -39,4 1.67% | -28,2 -34,4 18.16% | -26,0 -28,3 7.99% | -22,7 -28,3 19.72% | -26,8 -25,4 -5.77% | -23,0 -26,4 12.81% | -26,1 | -27,7 | -30,2 | -34,7 | -38,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -39,7 -33,6 -18.38% | -39,9 -37,7 -5.82% | -39,4 -42,1 6.48% | -37,9 -38,7 1.99% | -26,3 -36,6 27.98% | -25,3 -26,3 3.66% | -22,0 -27,0 18.36% | -25,2 -24,2 -4.2% | -21,8 -24,7 11.45% | -23,8 | -26,0 | -29,6 | -33,1 | -36,4 |
|
Net income Million USD | Released Forecast Spread | -39,7 -33,8 -17.52% | -39,9 -37,7 -5.84% | -39,4 -43,0 8.41% | -37,9 -39,3 3.36% | -26,3 -28,3 6.83% | -25,3 -26,6 5.05% | -22,0 -28,1 21.7% | -25,2 -25,2 0.14% | -21,8 -25,6 14.84% | -24,8 | -26,0 | -29,0 | -33,1 | -36,4 |
|
EPS USD | Released Forecast Spread | -1,40 -1,27 -10.61% | -1,33 -1,27 -4.49% | -1,31 -1,46 10.48% | -1,26 -1,33 5.41% | -0,87 -0,89 2.25% | -0,84 -0,90 6.32% | -0,73 -0,91 20.13% | -0,84 -0,83 -1.2% | -0,72 -0,86 16.28% | -0,83 | -0,78 | -0,72 | -0,94 | -1,03 |
| Announcement Date | 05/05/22 | 11/08/22 | 10/11/22 | 23/03/23 | 11/05/23 | 08/08/23 | 08/11/23 | 19/03/24 | 08/05/24 | - | - | - | - | - |
More events
Past sector events for Relmada Therapeutics, Inc.
| 11/07/2024 21:00 | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
| 08/07/2024 | LUMOSA THERAPEUTICS CO., LTD.: June 2024 Sales and Revenue Release |
| 07/07/2024 | TAIMED BIOLOGICS INC.: June 2024 Sales and Revenue Release |
| 04/07/2024 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
| 06/06/2024 | LUMOSA THERAPEUTICS CO., LTD.: May 2024 Sales and Revenue Release |
| 06/06/2024 | TAIMED BIOLOGICS INC.: May 2024 Sales and Revenue Release |
| 05/06/2024 08:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RLMD Stock
- RLMD Stock
- Calendar Relmada Therapeutics, Inc.
